Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study

References

• PatelJNemotoTRosnerDDaoTLPickrenJWAxillary lymph node metastasis from an occult breast cancerCancer19814712292329277260879
   PubMed Web of Science ®Google Scholar
• RosenPPAxillary lymph node metastases in patients with occult noninvasive breast carcinomaCancer1980465129813066260331
   PubMed Web of Science ®Google Scholar
• OwenHWDockertyMBGrayHKOccult carcinoma of the breastSurg Gynecol Obstet195498330230813146478
   PubMedGoogle Scholar
• PavlidisNPentheroudakisGCancer of unknown primary siteLancet201237998241428143522414598
   PubMed Web of Science ®Google Scholar
• PentheroudakisGLazaridisGPavlidisNAxillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidenceBreast Cancer Res Treat2010119111119771506
   PubMed Web of Science ®Google Scholar
• SohnGSonBHLeeSJTreatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective studyJ Surg Oncol2014110327027424863883
   PubMed Web of Science ®Google Scholar
• WalkerGVSmithGLPerkinsGHPopulation-based analysis of occult primary breast cancer with axillary lymph node metastasisCancer2010116174000400620564117
   PubMed Web of Science ®Google Scholar
• HeMTangLCYuKDKdYTreatment outcomes and unfavorable prognostic factors in patients with occult breast cancerEur J Surg Oncol201238111022102822959166
   PubMed Web of Science ®Google Scholar
• RosenPPKimmelMOccult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patientsHum Pathol19902155185232338331
   PubMed Web of Science ®Google Scholar
• MontagnaEBagnardiVRotmenszNImmunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentationBreast Cancer Res Treat2011129386787521822638
   PubMed Web of Science ®Google Scholar
• PingSMingWHBinSHComparison of clinical characteristics between occult and non-occult breast cancerJ Buon201419366266625261649
   PubMed Web of Science ®Google Scholar
• JacksonBScott-ConnerCMoulderJAxillary metastasis from occult breast carcinoma: diagnosis and managementAm Surg19956154314347733550
   PubMed Web of Science ®Google Scholar
• SvasticsERónayPBodóMOccult breast cancer presenting with axillary metastasisEur J Surg Oncol19931965755808270047
   PubMedGoogle Scholar
• National Comprehensive Cancer Network (NCCN)Clinical Practice Guidelines in Oncology, Breast Cancer v3.20172017
   Google Scholar
• BlanchardDKShettyPBHilsenbeckSGElledgeRMAssociation of surgery with improved survival in stage IV breast cancer patientsAnn Surg2008247573273818438108
   PubMed Web of Science ®Google Scholar
• OlsonJAMorrisEAvan ZeeKJLinehanDCBorgenPIMagnetic resonance imaging facilitates breast conservation for occult breast cancerAnn Surg Oncol20007641141510894136
   PubMed Web of Science ®Google Scholar
• VaradarajanREdgeSBYuJWatrobaNJanarthananBRPrognosis of occult breast carcinoma presenting as isolated axillary nodal metastasisOncology2006715–645645917690561
   PubMed Web of Science ®Google Scholar
• StephenBEByrdDRMichaelAM AJCC Cancer Staging Manual7th edNew YorkSpringer2010
   Google Scholar
• AustinPCStatistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity scoreAm J Epidemiol201017291092109720802241
   PubMed Web of Science ®Google Scholar
• HesslerLKMolitorisJKRosenblattPYFactors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer DatabaseAnn Surg Oncol201724102907291428766198
   PubMed Web of Science ®Google Scholar
• AmirEMillerNGeddieWProspective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancerJ Clin Oncol201230658759222124102
   PubMed Web of Science ®Google Scholar
• LindströmLSKarlssonEWilkingUMClinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progressionJ Clin Oncol201230212601260822711854
   PubMed Web of Science ®Google Scholar
• PusztaiLVialeGKellyCMHudisCAEstrogenHCAEstrogen and HER-2 receptor discordance between primary breast cancer and metastasisOncologist201015111164116821041379
   PubMed Web of Science ®Google Scholar
• KhasrawMBrogiESeidmanADThe need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?Curr Oncol Rep2011131172521053108
   PubMed Web of Science ®Google Scholar
• CurtitENerichVMansiLDiscordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasisOncologist201318666767423723333
   PubMed Web of Science ®Google Scholar
• PentheroudakisGBriasoulisEPavlidisNCancer of unknown primary site: missing primary or missing biology?Oncologist200712441842517470684
   PubMed Web of Science ®Google Scholar
• PavlidisNBriasoulisEHainsworthJGrecoFADiagnostic and therapeutic management of cancer of an unknown primaryEur J Cancer200339141990200512957453
   PubMed Web of Science ®Google Scholar
• HalstedWSIThe Results of Radical Operations for the Cure of Carcinoma of the BreastAnn Surg1907461119
   PubMedGoogle Scholar
• WangXZhaoYCaoXClinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastasesBreast J2010161323720465598
   PubMed Web of Science ®Google Scholar
• MersonMAndreolaSGalimbertiVBufalinoRMarchiniSVeronesiUBreast carcinoma presenting as axillary metastases without evidence of a primary tumorCancer19927025045081617600
   PubMed Web of Science ®Google Scholar
• AbbruzzeseJLAbbruzzeseMCLenziRHessKRRaberMNAnalysis of a diagnostic strategy for patients with suspected tumors of unknown originJ Clin Oncol1995138209421037636553
   PubMed Web of Science ®Google Scholar
• KemenyMMRiveraDETerzJJBenfieldJROccult primary adenocarcinoma with axillary metastasesAm J Surg1986152143473728816
   PubMed Web of Science ®Google Scholar
• BartonSRSmithIEKirbyAMAshleySWalshGPartonMThe role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathyEur J Cancer201147142099210621658935
   PubMed Web of Science ®Google Scholar
• ShannonCWalshGSapunarFA’HernRSmithIOccult primary breast carcinoma presenting as axillary lymphadenopathyBreast200211541441814965705
   PubMed Web of Science ®Google Scholar
• ForoudiFTiverKWOccult breast carcinoma presenting as axillary metastasesInt J Radiat Oncol Biol Phys200047114314710758316
   PubMed Web of Science ®Google Scholar
• BlanchardDKFarleyDRRetrospective study of women presenting with axillary metastases from occult breast carcinomaWorld J Surg200428653553915366740
   PubMed Web of Science ®Google Scholar
• RuethNMBlackDMLimmerARBreast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancerAnn Surg Oncol2015221909525249256
   PubMed Web of Science ®Google Scholar
• CampanaFFourquetAAshbyMAPresentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut CurieRadiother Oncol19891543213252552505
   PubMed Web of Science ®Google Scholar
• EllerbroekNHolmesFSingletaryEEvansHOswaldMMcneeseMTreatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast originCancer1990667146114672207996
   PubMed Web of Science ®Google Scholar
• KimBHKwonJKimKEvaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER DatabaseCancer Res Treat201850255156128602055
   PubMed Web of Science ®Google Scholar
• MacedoFIEidJJFlynnJJacobsMJMittalVKOptimal Surgical Management for Occult Breast Carcinoma: A Meta-analysisAnn Surg Oncol20162361838184426832884
   PubMed Web of Science ®Google Scholar
• CuriglianoGBursteinHJP WinerEPwEDe-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017Ann Oncol20172881700171228838210
   PubMed Web of Science ®Google Scholar